{"id":"W2911052757","doi":"10.1136/rmdopen-2018-000808","title":"Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond","year":2019,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Pfizer","keywords":"Medicine; Tofacitinib; Psoriatic arthritis; Placebo; Ankylosing spondylitis; Minimal clinically important difference; Internal medicine; Janus kinase inhibitor; Quality of life (healthcare); Randomized controlled trial; Physical therapy; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844383,0.0002967312,0.00152995,0.0002148958,0.00006316173,0.00005115662,0.0001242757,0.00006631597,0.00004998313],"category_scores_gemma":[0.000871982,0.0001656405,0.00009770213,0.000265669,0.00004329211,0.00018313,0.00007555798,0.000153648,0.000004554277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008852611,"about_ca_system_score_gemma":0.00006448117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006581689,"about_ca_topic_score_gemma":0.0002810408,"domain_scores_codex":[0.9974298,0.0007735944,0.0006807261,0.0004010889,0.0004243845,0.0002904396],"domain_scores_gemma":[0.9979168,0.001228639,0.000317242,0.0003399749,0.00007524028,0.0001221451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8586798,0.001713152,0.07291469,0.00001306468,0.0002241101,0.00008107573,0.003065467,0.000001735843,0.0001291042,0.000001436905,0.000009388753,0.06316692],"study_design_scores_gemma":[0.7820839,0.03802513,0.17761,0.0003186593,0.00009930456,0.000001768674,0.000419623,0.000004172018,0.001274267,0.000003975301,0.00002309712,0.0001361015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750124,0.00003623723,1.262969e-7,0.0001896171,0.0001484952,0.02426697,0.0001250153,0.000008829715,0.0002123425],"genre_scores_gemma":[0.998228,0.00001208871,0.00001315903,0.0001959212,0.00001158086,0.001405983,0.00006170585,0.00002443505,0.00004713543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1046953,"threshold_uncertainty_score":0.6754624,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01050387224145175,"score_gpt":0.3050748056780528,"score_spread":0.2945709334366011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}